Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc T.NUMI

Alternate Symbol(s):  NUMIF

Healthcare
Numinus Wellness Inc. is a Canada-based mental health care company. The Company helps people to heal and be well through the development and delivery of mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Company's segments include Clinical Research Operations, Canadian Clinic Network and US Clinic Network. Its Clinical Research Operations is focused on... see more

Recent & Breaking News (TSX:NUMI)

Numinus Announces Closing of $40-Million Bought Deal Financing

Canada NewsWire March 19, 2021

More People Are Turning to Psychedelics to Treat Mental Health Issues

Livemoney March 18, 2021

Health Conscious Consumers are Rapidly Turning to Functional Mushrooms

Livemoney March 16, 2021

Numinus Wellness Inc. (TSXV:NUMI) announces upsized bought deal public offering

John Ballem  March 15, 2021

IIROC Trading Resumption - NUMI

Canada NewsWire March 15, 2021

Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 million

GlobeNewswire March 15, 2021

IIROC Trading Halt - NUMI

Canada NewsWire March 15, 2021

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

GlobeNewswire March 15, 2021

Numinus to expand state-of-the-art psychedelics research laboratory

Canada NewsWire March 9, 2021

Psychedelics May Hold Significant Promise for Mental Health Care Treatment

Livemoney March 9, 2021

Regulatory approvals place Numinus lab at the forefront of global psychedelics research

Canada NewsWire March 4, 2021

Psychedelics Could Transform How You Treat Your Mental Health

Livemoney March 4, 2021

OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development

GlobeNewswire March 2, 2021

With Psilocybin, Significant Progress is Being Made with Substance Use Disorders

Livemoney March 2, 2021

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Canada NewsWire March 2, 2021

Innovators Identify Crucial Advancements to Uncover Medical Breakthroughs From Psychedelics

Livemoney March 2, 2021

This is Why Global Demand for Functional Mushrooms is On the Rise

Livemoney February 22, 2021

The StockTalk Cannabis Report: Feb 19, 2021

Dave Jackson February 19, 2021

Numinus & MAPS Trial for MDMA-Assisted Therapy Hits Key Milestones

Stockhouse Editorial February 18, 2021

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Canada NewsWire February 18, 2021